Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1393441-75-2
1408075-19-3
1630906-54-5
166168-16-7
180046-56-4
294180-29-3
873810-50-5 | 2-(2-Chloroacetamido)-N-(4-methoxyphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide | AA019P36 | MFCD01176785
1152621-92-5 | N-(1-acetylpiperidin-4-yl)-2-chloroacetamide | AA019P9Z | MFCD12147349
885530-72-3 | N1,N1-Diethyl-1-(3-methoxyphenyl)ethane-1,2-diamine | AA019PH2 | MFCD08444207
956769-09-8 | 2-Chloro-N-(1-(2-chlorobenzyl)-1H-pyrazol-5-yl)acetamide | AA019PN1 | MFCD08444306
1308987-90-7 | 2-([(4-Methylphenyl)carbamoyl]amino)propanoic acid | AA019PVG | MFCD12169864
280771-79-1 | 2-amino-4-chloro-N-(5-chloropyridin-2-yl)benzamide | AA019QK1 | MFCD11184855
1087789-00-1 | 2,2,2-trifluoroethyl N-(4-tert-butylphenyl)carbamate | AA019QSR | MFCD11099875
1094292-46-2 | 2-Chloro-4,5-dimethoxybenzenesulfonyl chloride | AA019RAO | MFCD13438190
57420-07-2 | 3-methyl-4-phenylpiperidine | AA019RPA | MFCD20441646
1394767-33-9 | 3-[2-Amino-4-(trifluoromethyl)phenyl]-4-methyl-5-(trifluoromethyl)-1,3-oxazolidin-2-one | AA019RUK | MFCD22392252
51486-03-4
1246088-51-6
1380300-72-0
457621-59-9
881073-44-5
1374539-32-8
Journal: Bioorganic & medicinal chemistry letters20101101